{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ABCA1", "PPAR\u03b3", "cholesterol efflux", "falcarindiol", "protein degradation"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "28919859", "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "09", "Day": "01"}], "Language": ["eng"], "ELocationID": ["596", "10.3389/fphar.2017.00596"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "8", "PubDate": {"Year": "2017"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "The Dietary Constituent Falcarindiol Promotes Cholesterol Efflux from THP-1 Macrophages by Increasing ABCA1 Gene Transcription and Protein Stability.", "Pagination": {"StartPage": "596", "MedlinePgn": "596"}, "Abstract": {"AbstractText": ["We report increased cholesterol efflux from macrophages in the presence of falcarindiol, an important dietary constituent present in commonly used vegetables and medicinal plants. Falcarindiol (3-20 \u03bcM) increased cholesterol efflux from THP-1-derived macrophages. Western blot analysis showed an increased protein level of ABCA1 upon falcarindiol exposure. Quantitative real-time PCR revealed that also ABCA1 mRNA level rise with falcarindiol (10 \u03bcM) treatment. The effect of falcarindiol on ABCA1 protein as well as mRNA level were counteracted by co-treatment with BADGE, an antagonist of PPAR\u03b3. Furthermore, falcarindiol significantly inhibited ABCA1 protein degradation in the presence of cycloheximide. This post-translational regulation of ABCA1 by falcarindiol occurs most likely by inhibition of lysosomal cathepsins, resulting in decreased proteolysis and extended protein half-life of ABCA1. Taken together, falcarindiol increases ABCA1 protein level by two complementary mechanisms, i.e., promoting ABCA1 gene expression and inhibiting ABCA1 protein degradation, which lead to enhanced cholesterol efflux."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, University of ViennaVienna, Austria."}, {"Identifier": [], "Affiliation": "Department of Pharmacology, School of Pharmacy, Qingdao UniversityQingdao, China."}], "LastName": "Wang", "ForeName": "Limei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, University of ViennaVienna, Austria."}], "LastName": "Palme", "ForeName": "Veronika", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, University of ViennaVienna, Austria."}], "LastName": "Schilcher", "ForeName": "Nicole", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, University of ViennaVienna, Austria."}], "LastName": "Ladurner", "ForeName": "Angela", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, University of ViennaVienna, Austria."}], "LastName": "Heiss", "ForeName": "Elke H", "Initials": "EH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Pathobiochemistry and Genetics, Institute of Medical Chemistry, Medical University of ViennaVienna, Austria."}], "LastName": "Stangl", "ForeName": "Herbert", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Institute of Pharmaceutical Sciences, Karl-Franzens-University GrazGraz, Austria."}], "LastName": "Bauer", "ForeName": "Rudolf", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, University of ViennaVienna, Austria."}], "LastName": "Dirsch", "ForeName": "Verena M", "Initials": "VM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, University of ViennaVienna, Austria."}, {"Identifier": [], "Affiliation": "Department of Molecular Biology, Institute of Genetics and Animal Breeding of the Polish Academy of SciencesLesznowola, Poland."}], "LastName": "Atanasov", "ForeName": "Atanas G", "Initials": "AG"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Appelqvist H., Waster P., Kagedal K., Ollinger K. (2013). The lysosome: from waste bag to potential therapeutic target. J. Mol. Cell Biol. 5, 214\u2013226. 10.1093/jmcb/mjt022", "ArticleIdList": ["10.1093/jmcb/mjt022", "23918283"]}, {"Citation": "Arakawa R., Tsujita M., Iwamoto N., Ito-Ohsumi C., Lu R., Wu C. A., et al. . (2009). Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis. J. Lipid Res. 50, 2299\u20132305. 10.1194/jlr.M900122-JLR200", "ArticleIdList": ["10.1194/jlr.M900122-JLR200", "PMC2759836", "19458386"]}, {"Citation": "Atanasov A. G., Blunder M., Fakhrudin N., Liu X., Noha S. M., Malainer C., et al. . (2013). Polyacetylenes from Notopterygium incisum-new selective partial agonists of peroxisome proliferator-activated receptor-gamma. Plos ONE 8:e61755. 10.1371/journal.pone.0061755", "ArticleIdList": ["10.1371/journal.pone.0061755", "PMC3632601", "23630612"]}, {"Citation": "Atanasov A. G., Waltenberger B., Pferschy-Wenzig E. M., Linder T., Wawrosch C., Uhrin P., et al. . (2015). Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol. Adv. 33, 1582\u20131614. 10.1016/j.biotechadv.2015.08.001", "ArticleIdList": ["10.1016/j.biotechadv.2015.08.001", "PMC4748402", "26281720"]}, {"Citation": "Beers C., Honey K., Fink S., Forbush K., Rudensky A. (2003). Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages. J. Exp. Med. 197, 169\u2013179. 10.1084/jem.20020978", "ArticleIdList": ["10.1084/jem.20020978", "PMC2193812", "12538657"]}, {"Citation": "Bracke K., Cataldo D., Maes T., Gueders M., Noel A., Foidart J. M., et al. . (2005). Matrix metalloproteinase-12 and cathepsin D expression in pulmonary macrophages and dendritic cells of cigarette smoke-exposed mice. Int. Arch. Allergy Immunol. 138, 169\u2013179. 10.1159/000088439", "ArticleIdList": ["10.1159/000088439", "16192742"]}, {"Citation": "Chawla A., Boisvert W. A., Lee C. H., Laffitte B. A., Barak Y., Joseph S. B., et al. . (2001). A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell. 7, 161\u2013171. 10.1016/S1097-2765(01)00164-2", "ArticleIdList": ["10.1016/S1097-2765(01)00164-2", "11172721"]}, {"Citation": "Chen J., Tung C. H., Mahmood U., Ntziachristos V., Gyurko R., Fishman M. C., et al. . (2002). In vivo imaging of proteolytic activity in atherosclerosis. Circulation 105, 2766\u20132771. 10.1161/01.CIR.0000017860.20619.23", "ArticleIdList": ["10.1161/01.CIR.0000017860.20619.23", "12057992"]}, {"Citation": "Chinetti G., Lestavel S., Bocher V., Remaley A. T., Neve B., Torra I. P., et al. . (2001). PPAR-\u03b1 and PPAR-\u03b3 activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat. Med. 7, 53\u201358. 10.1038/83348", "ArticleIdList": ["10.1038/83348", "11135616"]}, {"Citation": "Du X. M., Kim M. J., Hou L. M., Le Goff W., Chapman M. J., Van Eck M., et al. . (2015). HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. Circ. Res. 116, 1133\u20131142. 10.1161/CIRCRESAHA.116.305485", "ArticleIdList": ["10.1161/CIRCRESAHA.116.305485", "25589556"]}, {"Citation": "Duffy D., Rader D. J. (2006). Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport. Circulation 113, 1140\u20131150. 10.1161/CIRCULATIONAHA.105.593855", "ArticleIdList": ["10.1161/CIRCULATIONAHA.105.593855", "16505192"]}, {"Citation": "Fielding C. J., Fielding P. E. (1995). Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36, 211\u2013228.", "ArticleIdList": ["7751809"]}, {"Citation": "Garrod B., Lewis B. G., Coxon D. T. (1978). Cis-Heptadeca-1,9-Diene-4,6-Diyne-3,8-Diol, an antifungal polyacetylene from carrot root-tissue. Physiol. Plant. Pathol. 13, 241\u2013246. 10.1016/0048-4059(78)90039-5", "ArticleIdList": ["10.1016/0048-4059(78)90039-5"]}, {"Citation": "Gelissen I. C., Cartland S., Brown A. J., Sandoval C., Kim M., Dinnes D. L., et al. . (2010). Expression and stability of two isoforms of ABCG1 in human vascular cells. Atherosclerosis 208, 75\u201382. 10.1016/j.atherosclerosis.2009.06.028", "ArticleIdList": ["10.1016/j.atherosclerosis.2009.06.028", "19651406"]}, {"Citation": "Gelissen I. C., Harris M., Rye K. A., Quinn C., Brown A. J., Kockx M., et al. . (2006). ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler. Thromb. Vasc. Biol. 26, 534\u2013540. 10.1161/01.ATV.0000200082.58536.e1", "ArticleIdList": ["10.1161/01.ATV.0000200082.58536.e1", "16357317"]}, {"Citation": "Hinz B., Brune K., Pahl A. (2003). 15-Deoxy-\u0394(12, 14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-\u03b3-independent mechanism. Biochem. Biophys. Res. Commun. 302, 415\u2013420. 10.1016/S0006-291X(03)00195-5", "ArticleIdList": ["10.1016/S0006-291X(03)00195-5", "12604364"]}, {"Citation": "Hsieh V., Kim M. J., Gelissen I. C., Brown A. J., Sandoval C., Hallab J. C., et al. . (2014). Cellular cholesterol regulates ubiquitination and degradation of the cholesterol export proteins ABCA1 and ABCG1. J. Biol. Chem. 289, 7524\u20137536. 10.1074/jbc.M113.515890", "ArticleIdList": ["10.1074/jbc.M113.515890", "PMC3953266", "24500716"]}, {"Citation": "Kemp M. S. (1978). Falcarindiol - antifungal polyacetylene from Aegopodium-podagraria. Phytochemistry 17, 1002\u20131002. 10.1016/S0031-9422(00)88669-0", "ArticleIdList": ["10.1016/S0031-9422(00)88669-0"]}, {"Citation": "Lindstedt L., Lee M., Oorni K., Bromme D., Kovanen P. T. (2003). Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells. Biochem. Biophys. Res. Commun. 312, 1019\u20131024. 10.1016/j.bbrc.2003.11.020", "ArticleIdList": ["10.1016/j.bbrc.2003.11.020", "14651973"]}, {"Citation": "Liu X., Kunert O., Blunder M., Fakhrudin N., Noha S. M., Malainer C., et al. . (2014). Polyyne hybrid compounds from Notopterygium incisum with peroxisome proliferator-activated receptor gamma agonistic effects. J. Nat. Prod. 77, 2513\u20132521. 10.1021/np500605v", "ArticleIdList": ["10.1021/np500605v", "PMC4251066", "25333853"]}, {"Citation": "Liu Y. H., Tang C. R. (2012). Regulation of ABCA1 functions by signaling pathways. Biochim. Biophys. Acta 1821, 522\u2013529. 10.1016/j.bbalip.2011.08.015", "ArticleIdList": ["10.1016/j.bbalip.2011.08.015", "PMC3243790", "21920460"]}, {"Citation": "Lutgens E., Lutgens S. P., Faber B. C., Heeneman S., Gijbels M. M., de Winther M. P., et al. . (2006). Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation 113, 98\u2013107. 10.1161/CIRCULATIONAHA.105.561449", "ArticleIdList": ["10.1161/CIRCULATIONAHA.105.561449", "16365196"]}, {"Citation": "Lutgens S. P., Cleutjens K. B., Daemen M. J., Heeneman S. (2007). Cathepsin cysteine proteases in cardiovascular disease. FASEB J. 21, 3029\u20133041. 10.1096/fj.06-7924com", "ArticleIdList": ["10.1096/fj.06-7924com", "17522380"]}, {"Citation": "Matveev S., van der Westhuyzen D. R., Smart E. J. (1999). Co-expression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages. J. Lipid Res. 40, 1647\u20131654.", "ArticleIdList": ["10484611"]}, {"Citation": "Mizuno T., Hayashi H., Naoi S., Sugiyama Y. (2011). Ubiquitination is associated with lysosomal degradation of cell surface-resident atp-binding cassette transporter a1 (abca1) through the endosomal sorting complex required for transport (escrt) pathway. Hepatology 54, 631\u2013643. 10.1002/hep.24387", "ArticleIdList": ["10.1002/hep.24387", "21520210"]}, {"Citation": "Neufeld E. B., Remaley A. T., Demosky S. J., Stonik J. A., Cooney A. M., Comly M., et al. . (2001). Cellular localization and trafficking of the human ABCA1 transporter. J. Biol. Chem. 276, 27584\u201327590. 10.1074/jbc.M103264200", "ArticleIdList": ["10.1074/jbc.M103264200", "11349133"]}, {"Citation": "Ozasa H., Ayaori M., Iizuka M., Terao Y., Uto-Kondo H., Yakushiji E., et al. (2011). Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPAR \u03b3/LXR \u03b1 pathway: findings from in vitro and ex vivo studies. Atherosclerosis 219, 141\u2013150. 10.1016/j.atherosclerosis.2011.07.113", "ArticleIdList": ["10.1016/j.atherosclerosis.2011.07.113", "21862012"]}, {"Citation": "Punturieri A., Filippov S., Allen E., Caras I., Murray R., Reddy V., et al. . (2000). Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J. Exp. Med. 192, 789\u2013799. 10.1084/jem.192.6.789", "ArticleIdList": ["10.1084/jem.192.6.789", "PMC2193285", "10993910"]}, {"Citation": "Rohatgi A., Khera A., Berry J. D., Givens E. G., Ayers C. R., Wedin K. E., et al. . (2014). HDL cholesterol efflux capacity and incident cardiovascular events. New Engl. J. Med. 371, 2383\u20132393. 10.1056/NEJMoa1409065", "ArticleIdList": ["10.1056/NEJMoa1409065", "PMC4308988", "25404125"]}, {"Citation": "Rosenson R. S., Brewer H. B., Davidson W. S., Fayad Z. A., Fuster V., Goldstein J., et al. . (2012). Cholesterol efflux and atheroprotection advancing the concept of reverse cholesterol transport. Circulation 125, 1905\u20131919. 10.1161/CIRCULATIONAHA.111.066589", "ArticleIdList": ["10.1161/CIRCULATIONAHA.111.066589", "PMC4159082", "22508840"]}, {"Citation": "Santamarina-Fojo S., Remaley A. T., Neufeld E. B., Brewer H. B. (2001). Regulation and intracellular trafficking of the ABCA1 transporter. J. Lipid Res. 42, 1339\u20131345.", "ArticleIdList": ["11518753"]}, {"Citation": "Stangl H., Hyatt M., Hobbs H. H. (1999). Transport of lipids from high and low density lipoproteins via scavenger receptor-BI. J. Biol. Chem. 274, 32692\u201332698. 10.1074/jbc.274.46.32692", "ArticleIdList": ["10.1074/jbc.274.46.32692", "10551825"]}, {"Citation": "Sukhova G. K., Zhang Y., Pan J. H., Wada Y., Yamamoto T., Naito M., et al. . (2003). Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 111, 897\u2013906. 10.1172/JCI200314915", "ArticleIdList": ["10.1172/JCI200314915", "PMC153760", "12639996"]}, {"Citation": "Turk V., Stoka V., Vasiljeva O., Renko M., Sun T., Turk B., et al. . (2012). Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim. Biophys. Acta 1824, 68\u201388. 10.1016/j.bbapap.2011.10.002", "ArticleIdList": ["10.1016/j.bbapap.2011.10.002", "PMC7105208", "22024571"]}, {"Citation": "Vasiljeva O., Papazoglou A., Krueger A., Brodoefel H., Korovin M., Deussing J., et al. . (2006). Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res. 66, 5242\u20135250. 10.1158/0008-5472.CAN-05-4463", "ArticleIdList": ["10.1158/0008-5472.CAN-05-4463", "16707449"]}, {"Citation": "Wang L., Rotter S., Ladurner A., Heiss E. H., Oberlies N. H., Dirsch V. M., et al. . (2015). Silymarin constituents enhance ABCA1 expression in THP-1 macrophages. Molecules 21:e55. 10.3390/molecules21010055", "ArticleIdList": ["10.3390/molecules21010055", "PMC4748397", "26729088"]}, {"Citation": "Wang N., Chen W. G., Linsel-Nitschke P., Martinez L. O., Agerholm-Larsen B., Silver D. L., et al. . (2003). A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J. Clin. Invest. 111, 99\u2013107. 10.1172/JCI200316808", "ArticleIdList": ["10.1172/JCI200316808", "PMC151839", "12511593"]}, {"Citation": "Yokoyama S., Arakawa R., Wu C., Iwamoto N., Lu R., Tsujita M., et al. . (2012). Calpain-mediated ABCA1 degradation: post-translational regulation of ABCA1 for HDL biogenesis. Biochim. Biophys. Acta 1821, 547\u2013551. 10.1016/j.bbalip.2011.07.017", "ArticleIdList": ["10.1016/j.bbalip.2011.07.017", "21835264"]}, {"Citation": "Zidorn C., Johrer K., Ganzera M., Schubert B., Sigmund E. M., Mader J., et al. . (2005). Polyacetylenes from the Apiaceae vegetables carrot, celery, fennel, parsley, and parsnip and their cytotoxic activities. J. Agric. Food Chem. 53, 2518\u20132523. 10.1021/jf048041s", "ArticleIdList": ["10.1021/jf048041s", "15796588"]}, {"Citation": "Zschocke S., Lehner M., Bauer R. (1997). 5-lipoxygenase and cyclooxygenase inhibitory active constituents from Qianghuo (Notopterygium incisum). Planta Med. 63, 203\u2013206. 10.1055/s-2006-957653", "ArticleIdList": ["10.1055/s-2006-957653", "9265192"]}]}], "History": [{"Year": "2017", "Month": "6", "Day": "10"}, {"Year": "2017", "Month": "8", "Day": "17"}, {"Year": "2017", "Month": "9", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "9", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "9", "Day": "19", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "9", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["28919859", "PMC5585181", "10.3389/fphar.2017.00596"]}}]}